Topics

ResTORbio Takes Immunotherapy Approach To Reducing Respiratory Tract Infections

14:45 EDT 4 Oct 2019 | SCRIP

Repurposing a TORC1 inhibitor investigated in several cancer types at Novartis, resTORbio has initiated a second Phase III study of...

      

Related Stories

 

Original Article: ResTORbio Takes Immunotherapy Approach To Reducing Respiratory Tract Infections

NEXT ARTICLE

More From BioPortfolio on "ResTORbio Takes Immunotherapy Approach To Reducing Respiratory Tract Infections"

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...